deferasirox has been researched along with Acute Confusional Senile Dementia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baum, L; Ho, A; Kwan, P | 1 |
| Amini, M; Atyabi, F; Dinarvand, R; Kamalinia, G; Khodagholi, F; Shaerzadeh, F; Sharifzadeh, M | 1 |
| Amini, M; Atyabi, F; Chaharband, F; Dinarvand, R; Kamalinia, G; Khodagholi, F; Shaerzadeh, F; Sharifzadeh, M; Tavssolian, F | 1 |
| Liu, G; Men, P; Perry, G; Smith, MA | 1 |
| Waugh, WH | 1 |
5 other study(ies) available for deferasirox and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Effects of Deferasirox in Alzheimer's Disease and Tauopathy Animal Models.
Topics: Alzheimer Disease; Animals; Deferasirox; Deferoxamine; Disease Models, Animal; Humans; Iron; Iron Chelating Agents; Mice; Mice, Transgenic; tau Proteins; Tauopathies | 2022 |
Enhanced brain delivery of deferasirox-lactoferrin conjugates for iron chelation therapy in neurodegenerative disorders: in vitro and in vivo studies.
Topics: Alzheimer Disease; Animals; Apoptosis; Apoptosis Regulatory Proteins; Benzoates; Brain; Carbodiimides; Cell Line, Tumor; Chelating Agents; Chelation Therapy; Deferasirox; Disease Models, Animal; Drug Delivery Systems; Iron; Lactoferrin; Male; Nanostructures; Neurodegenerative Diseases; Neuroprotective Agents; PC12 Cells; Permeability; Rats; Rats, Wistar; Transcytosis; Triazoles | 2013 |
Cationic albumin-conjugated chelating agent as a novel brain drug delivery system in neurodegeneration.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Benzoates; Brain; Cations; Deferasirox; Drug Carriers; Drug Delivery Systems; Humans; Iron Chelating Agents; Male; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Rats; Rats, Wistar; Serum Albumin; Triazoles | 2015 |
Nanoparticle and iron chelators as a potential novel Alzheimer therapy.
Topics: Aged; Alzheimer Disease; Benzoates; Blood-Brain Barrier; Brain; Chelation Therapy; Deferasirox; Deferoxamine; Drug Carriers; Ferritins; Humans; Iron; Iron Chelating Agents; Metals; Molecular Structure; Nanoparticles; Triazoles | 2010 |
Cognitive declines therapy by iron burden reduction.
Topics: Alzheimer Disease; Benzoates; Deferasirox; Ferritins; Humans; Iron; Iron Chelating Agents; Middle Aged; Triazoles | 2007 |